News Sentiment

AVLN sentiment intelligence

Avalyn Pharma Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 28.30 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

+0.9% over one week, -10.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Price to sales forward of Avalyn Pharma Inc. – NASDAQ:AVLN

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction 0.9% Price digesting
Trend fit Trend inactive -10.0% over four weeks
Fair value -3.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 37
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
MarketBeat 7
TradingView 5
GlobeNewswire 4
MT Newswires 2
Investing.com 2
simplywall.st 2
TIKR.com 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 17
Analyst action 5
Guidance 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 53
Associated Press Direct company coverage

Avalyn: Q1 Earnings Snapshot

Tone
Neutral 50/100
Event
Earnings
Published
03 Jun 2026 12:07
Source
Associated Press